Kunshi Biology: Net loss in the first quarter of 2025 was 235 million yuan.

Junshi Biotech announced that its revenue for the first quarter of 2025 was 5.01 billion yuan, a year-on-year increase of 31.46%; net loss was 2.35 billion yuan, compared to a net loss of 2.83 billion yuan in the same period last year.